Actelion Ltd. ALIOF reported second-quarter 2016 earnings of $2.13 per American Depository Receipt (ADR), up from the year-ago figure of $1.60. Reported earnings were also above the Zacks Consensus Estimate of $1.86. Revenues were up 16.1% year over year to $607.7 million, beating the Zacks Consensus Estimate of $589 million. Quarter in Detail All growth rates mentioned below are in constant exchange rates and on a year-over-year basis. Product sales were up 15%. Sales surged 25% in the U.S. driven by the launch of Uptravi, continued momentum in Opsumit and share gains in the endothelin receptor antagonist (ERA) market....
↧